This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Larson, J.E. Articles by Angle, C.R. Search for Related Content PubMed Articles by Larson, J.E. Articles by Angle, C.R. Social Bookmarking                         What's this?

Laxative Phosphate Poisoning: Pharmacokinetics of Serum Phosphorus

Department of Pediatrics, University of Nebraska Medical Center, Omaha, Nebraska 68105, USA

S.A. Swigart

Department of Pediatrics, University of Nebraska Medical Center, Omaha, Nebraska 68105, USA

C.R. Angle

Department of Pediatrics, University of Nebraska Medical Center, Omaha, Nebraska 68105, USA

Despite the frequency of acute poisoning in normal children by oral or rectal phosphosoda laxatives, the rate of clearance of the resultant high level of phosphorus and the rationale for therapy are defined incompletely.

1 Pharmacokinetic analysis has been made of plasma inorganic phosphate (P_i) in an infant after ingestion of phosphosoda laxative and of data reported for four comparable poisonings in healthy infants to provide a nomogram which predicts the decline in P_i in paediatric phosphate poisoning.

2 Clearance of Pi is exponential; it directly correlates with and approaches the glomerular filtration rate.

3 After single oral or rectal overdoses, plasma Pi at diagnosis is 4-20 mmoul and has a half-life of 5-11 h that appears independent of therapy. The time for plasma Pi to return to normal can be calculated from the initial Pi as t = (In 5/P_i )/0.1292.

4 Neuromuscular and cardiac abnormalities relate to the low serum calcium; the increase of total serum calcium during recovery from phosphate poisoning is linear but is accelerated by intravenous (i.v.) calcium salt. Continued i.v. calcium therapy may be required since restoration of plasma calcium is often delayed.

Human & Experimental Toxicology, Vol. 5, No. 1, 45-49 (1986)
DOI: 10.1177/096032718600500109


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?